Cargando…

Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice

Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jide, Dang, Hoa, Nguyen, An Viet, Chen, Zheying, Kaufman, Daniel L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141368/
https://www.ncbi.nlm.nih.gov/pubmed/25146474
http://dx.doi.org/10.2337/db13-1385
_version_ 1782331640344739840
author Tian, Jide
Dang, Hoa
Nguyen, An Viet
Chen, Zheying
Kaufman, Daniel L.
author_facet Tian, Jide
Dang, Hoa
Nguyen, An Viet
Chen, Zheying
Kaufman, Daniel L.
author_sort Tian, Jide
collection PubMed
description Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic responses while ABT-induced regulatory responses arose and spread. γ-Aminobutyric acid (GABA) administration can inhibit inflammation, enhance regulatory T-cell (Treg) responses, and promote β-cell replication in mice. We examined the effect of combining a prototypic ABT, proinsulin/alum, with GABA treatment in newly diabetic NOD mice. Proinsulin/alum monotherapy failed to correct hyperglycemia, while GABA monotherapy restored normoglycemia for a short period. Combined treatment restored normoglycemia in the long term with apparent permanent remission in some mice. Proinsulin/alum monotherapy induced interleukin (IL)-4– and IL-10–secreting T-cell responses that spread to other β-cell autoantigens. GABA monotherapy induced moderate IL-10 (but not IL-4) responses to β-cell autoantigens. Combined treatment synergistically reduced spontaneous type 1 T-helper cell responses to autoantigens, ABT-induced IL-4 and humoral responses, and insulitis, but enhanced IL-10 and Treg responses and promoted β-cell replication in the islets. Thus, combining ABT with GABA can inhibit pathogenic T-cell responses, induce Treg responses, promote β-cell replication, and effectively restore normoglycemia in newly diabetic NOD mice. Since these treatments appear safe for humans, they hold promise for type 1 diabetes intervention.
format Online
Article
Text
id pubmed-4141368
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-41413682015-09-01 Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice Tian, Jide Dang, Hoa Nguyen, An Viet Chen, Zheying Kaufman, Daniel L. Diabetes Pharmacology and Therapeutics Antigen-based therapies (ABTs) fail to restore normoglycemia in newly diabetic NOD mice, perhaps because too few β-cells remain by the time that ABT-induced regulatory responses arise and spread. We hypothesized that combining a fast-acting anti-inflammatory agent with an ABT could limit pathogenic responses while ABT-induced regulatory responses arose and spread. γ-Aminobutyric acid (GABA) administration can inhibit inflammation, enhance regulatory T-cell (Treg) responses, and promote β-cell replication in mice. We examined the effect of combining a prototypic ABT, proinsulin/alum, with GABA treatment in newly diabetic NOD mice. Proinsulin/alum monotherapy failed to correct hyperglycemia, while GABA monotherapy restored normoglycemia for a short period. Combined treatment restored normoglycemia in the long term with apparent permanent remission in some mice. Proinsulin/alum monotherapy induced interleukin (IL)-4– and IL-10–secreting T-cell responses that spread to other β-cell autoantigens. GABA monotherapy induced moderate IL-10 (but not IL-4) responses to β-cell autoantigens. Combined treatment synergistically reduced spontaneous type 1 T-helper cell responses to autoantigens, ABT-induced IL-4 and humoral responses, and insulitis, but enhanced IL-10 and Treg responses and promoted β-cell replication in the islets. Thus, combining ABT with GABA can inhibit pathogenic T-cell responses, induce Treg responses, promote β-cell replication, and effectively restore normoglycemia in newly diabetic NOD mice. Since these treatments appear safe for humans, they hold promise for type 1 diabetes intervention. American Diabetes Association 2014-09 2014-08-16 /pmc/articles/PMC4141368/ /pubmed/25146474 http://dx.doi.org/10.2337/db13-1385 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
spellingShingle Pharmacology and Therapeutics
Tian, Jide
Dang, Hoa
Nguyen, An Viet
Chen, Zheying
Kaufman, Daniel L.
Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
title Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
title_full Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
title_fullStr Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
title_full_unstemmed Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
title_short Combined Therapy With GABA and Proinsulin/Alum Acts Synergistically to Restore Long-term Normoglycemia by Modulating T-Cell Autoimmunity and Promoting β-Cell Replication in Newly Diabetic NOD Mice
title_sort combined therapy with gaba and proinsulin/alum acts synergistically to restore long-term normoglycemia by modulating t-cell autoimmunity and promoting β-cell replication in newly diabetic nod mice
topic Pharmacology and Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141368/
https://www.ncbi.nlm.nih.gov/pubmed/25146474
http://dx.doi.org/10.2337/db13-1385
work_keys_str_mv AT tianjide combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice
AT danghoa combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice
AT nguyenanviet combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice
AT chenzheying combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice
AT kaufmandaniell combinedtherapywithgabaandproinsulinalumactssynergisticallytorestorelongtermnormoglycemiabymodulatingtcellautoimmunityandpromotingbcellreplicationinnewlydiabeticnodmice